Esperion Therapeutics
ESPR
#6378
Rank
A$1.16 B
Marketcap
A$4.88
Share price
-4.51%
Change (1 day)
65.60%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: A$1.16 Billion

As of February 2026 Esperion Therapeutics has a market cap of A$1.16 Billion. This makes Esperion Therapeutics the world's 6378th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$1.16 B-18.44%
2025A$1.42 B97.98%
2024A$0.72 B44.72%
2023A$0.49 B-26.02%
2022A$0.67 B60.61%
2021A$0.42 B-52.07%
2020A$0.87 B-62.58%
2019A$2.34 B33.71%
2018A$1.75 B-20.72%
2017A$2.20 B463.99%
2016A$0.39 B-43.06%
2015A$0.68 B-31.56%
2014A$1.00 B325.39%
2013A$0.23 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Esperion Therapeutics was reported to be:

A$1.16 Billion
by Nasdaq info icon info icon
A$1.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$216.32 B 18,449.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$113.08 B 9,596.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A$3.34 B 186.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
A$0.60 B-47.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$6.45 B 453.15%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$15.63 B 1,240.30%๐Ÿ‡บ๐Ÿ‡ธ USA